PVI
GLSI icon

Pura Vida Investments’s Greenwich LifeSciences GLSI Stock Holding History

Pura Vida Investments’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,667
Closed -$179K – 212
2022
Q3 		$179K Buy
+19,667
New +$182K 0.01% 184

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Pura Vida Investments's GLSI Position: Q4 2022 in Review

Pura Vida Investments sold out of Greenwich LifeSciences (GLSI) in Q4 2022, closing a stake of 19,667 shares — an estimated $179K sold.

Pura Vida Investments first reported a position in GLSI in Q3 2022 and held it in 1 quarter. The position peaked at $179K in Q3 2022. 22 funds tracked by Wall St. Rank hold GLSI as of Q4 2022.

  • Pura Vida Investments reported no remaining Greenwich LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 19,667 Greenwich LifeSciences shares in Q4 2022, an estimated $179K.
  • Pura Vida Investments first reported a position in Greenwich LifeSciences in Q3 2022 and held it in 1 quarter.
  • Pura Vida Investments's Greenwich LifeSciences position peaked at $179K in Q3 2022.
  • 22 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.